drug-likeness central nervous system multiparameter optimization (cns mpo) algorithm (Pfizer Inc)
90
Structured Review
Pfizer Inc
drug-likeness central nervous system multiparameter optimization (cns mpo) algorithm
Drug Likeness Central Nervous System Multiparameter Optimization (Cns Mpo) Algorithm, supplied by Pfizer Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/multiparameter+optimization+algorithm+(cns+mpo)/drug+likeness+central+nervous+system+multiparameter+optimization++cns+mpo++algorithm/pm34653944-90-13-25
Average 90 stars, based on 1 article reviews
Drug Likeness Central Nervous System Multiparameter Optimization (Cns Mpo) Algorithm, supplied by Pfizer Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/multiparameter+optimization+algorithm+(cns+mpo)/drug+likeness+central+nervous+system+multiparameter+optimization++cns+mpo++algorithm/pm34653944-90-13-25
Average 90 stars, based on 1 article reviews
drug-likeness central nervous system multiparameter optimization (cns mpo) algorithm - by Bioz Stars,
2026-11
90/100 stars
Images
Related Articles
other:Article Title: Guided rational design with scaffold hopping leading to novel histamine H 3 receptor ligands. Article Snippet: During the past decades, histamine H3 receptors have received widespread attention in pharmaceutical research due to their involvement in pathophysiology of several diseases such as neurodegenerative disorders.. In this context, blocking of these receptors is of paramount importance in progression of such diseases.. In the current investigation, novel histamine H3 receptor ligands were designed by exploiting scaffold-hopping drug-design strategy. |